# The District of Columbia Clinical Trials Unit (DC CTU)

> **NIH NIH UM1** · GEORGE WASHINGTON UNIVERSITY · 2021 · $2,283,095

## Abstract

Project Summary
The District of Columbia Clinical Trials Unit (DC CTU) will conduct clinical trials for persons with and at risk for
HIV in DC, where 1.8% of the overall population and 2.7% of the African-American population are living with
HIV. The DC CTU will unite two existing, high-performing DAIDS/NIAID Clinical Research Sites (CRS), the
Whitman-Walker Health CRS and the George Washington University CRS, in a new CTU, participating in the
HIV/AIDS Adult Therapeutics and HIV Prevention Clinical Trials Networks. Our innovative and geographically-
focused DC CTU will ensure exemplary clinical trials management, recruitment, and retention of a diverse
sample of participants, with a community engagement strategy built on existing partnerships and Good
Participatory Practices. The DC CTU will achieve four specific aims: 1) Provide scientific leadership and
administrative infrastructure to allow high-quality conduct of therapeutic and prevention studies at two
established CRSs; 2) Implement best practices to ensure continued high recruitment and retention rates;
participant safety; and laboratory, pharmacy, data, and regulatory excellence; 3) Actively engage with the local
community to ensure optimal enrollment of diverse participants from within and beyond clinic settings using
Good Participatory Practices; and 4) Capitalize on the resources available from the DC CFAR and DC Cohort
to engage senior investigators, mentor investigators in clinical trials conduct, and access a broad array of
services to address NIH and network scientific and programmatic priorities. The DC CTU will engage
participants who can benefit from innovative clinical trials while we contribute to high-quality participatory
research that will eventually end the HIV epidemic.

## Key facts

- **NIH application ID:** 10057532
- **Project number:** 1UM1AI154466-01
- **Recipient organization:** GEORGE WASHINGTON UNIVERSITY
- **Principal Investigator:** Sarah Henn
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $2,283,095
- **Award type:** 1
- **Project period:** 2020-12-01 → 2027-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10057532

## Citation

> US National Institutes of Health, RePORTER application 10057532, The District of Columbia Clinical Trials Unit (DC CTU) (1UM1AI154466-01). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10057532. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*